Presence of particulate matter:American Regent, Inc. notified BluePoint Pharmaceuticals Laboratories regarding potential glass particle contamination (foreign glass fragment) identified in the product batch.
✎ GovInfoNow plain-language explainer
American Health Packaging is recalling Cyanocobalamin Injection, USP, 1,000 mcg/mL because of potential foreign glass fragment contamination. The issue involves particulate matter found in the product batch supplied to BluePoint Laboratories. This recall affects specific cartons distributed nationwide. Read more at govinfonow.com/recall/2249329-american-health-packaging-recalls-cyanocobalamin-injection-usp-1-000-mcg.
“Recall: American Health Cyanocobalamin Injection Glass Particles.” GovInfoNow, updated November 17, 2026. https://govinfonow.com/recall/2249329-american-health-packaging-recalls-cyanocobalamin-injection-usp-1-000-mcg. Based on FDA recall #D-0173-2027 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0173-2027%22&limit=1).
The FDA announced on Oct. 22, 2026, that American Health Packaging is recalling Cyanocobalamin Injection due to potential glass particle contamination. The agency issued recall number D-0173-2027 for the voluntary Class II action.
American Regent, Inc. notified BluePoint Pharmaceuticals Laboratories regarding potential glass particle contamination identified in the product batch. The hazard involves the presence of foreign glass fragments.
Context
GovInfoNow's records show American Health Packaging has 43 other recalls on record since July 23, 2012. Recent brand recalls include a Metoclopramide Tablets recall on Oct. 6, 2026, and a Buprenorphine Tablets recall on Aug. 19, 2026. Other recent recalls of similar products include American Regent Cyanocobalamin Injection Recall (July 24, 2026), American Regent Papaverine HCl Injection Recall (July 24, 2026), and American Regent Aminocaproic Acid Injection Recall (July 24, 2026).
How to tell if you have this one
Check if you have Cyanocobalamin Injection, USP, 1,000 mcg/mL, Rx Only. Look for Carton NDC 68001-542-60 and Vial NDC 68001-542-59. Verify the Lot number is 24394A with an expiration date of 10-31-2026.
Brand
American Health Packaging
Category
Drug
Based on the official FDA remedy
What to do — step by step
Stop using the product
Do not administer or use any vials from the recalled lot due to glass contamination risk.
Contact your pharmacist or provider
Reach out to your healthcare provider or pharmacy for guidance on replacement or disposal, as no specific remedy details are provided in the record.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 20 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4Added to GovInfoNow
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0173-2027 (October 22, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0173-2027 to see it in context.
Plain-language summary written by qwen3.6:35b-a3b on November 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.